References

Cardiovascular manifestations and immunobiology of sarcoidosis

10.1161/atvbaha.125.323111 · 2026 · External reference

Challenges of sarcoidosis and its management

10.1056/nejmra2101555 · 2021 · External reference

Cardiac sarcoidosis

10.1016/j.jacc.2016.03.605 · 2016 · External reference

Integrative molecular analyses of inflammatory and autoimmune signals in cardiac sarcoidosis

10.1161/circulationaha.126.079304 · 2026 · External reference

The spatial and temporal activation of macrophages during fibrosis

10.1038/s41577-025-01186-x · 2025 · External reference

Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression

10.1038/ni.3655 · 2017 · External reference

An mTORC1-dependent mouse model for cardiac sarcoidosis

10.1161/jaha.123.030478 · 2023 · External reference

Multisystemic, possibly familial sarcoidosis ameliorated by an mTOR inhibitor

10.1016/j.jaccas.2025.103633 · 2025 · External reference

Use of sirolimus, an mTOR inhibitor, to treat sarcoidosis in multiple systems

10.1007/s12265-025-10700-4 · 2025 · External reference

10.1093/ajrccm/aamag354 · 2026 · Admitted local publication

Systems level identification of a matrisome-associated macrophage polarisation state in multi-organ fibrosis

10.7554/elife.85530 · 2023 · External reference

SPP1 macrophages across diseases: a call for reclassification?

10.1096/fj.202403227r · 2025 · External reference

Transcriptional and immune landscape of cardiac sarcoidosis

10.1161/circresaha.121.320449 · 2022 · External reference

Transcriptomic profiling of granuloma in patients with cardiac sarcoidosis

10.7150/thno.109211 · 2025 · External reference